Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study

BACKGROUND: There is no consensus on the optimal secondary antifungal prophylaxis (SAP) regimen in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The purpose of this study was to evaluate the efficacy and safety of posaconazole oral suspension as secondary prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Peipei, Pei, Renzhi, Hu, Youqian, Chen, Dong, Li, Shuangyue, Cao, Junjie, Li, Fenglin, Wu, Mengjie, Fang, Ying, Lu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107735/
https://www.ncbi.nlm.nih.gov/pubmed/35570276
http://dx.doi.org/10.1186/s12879-022-07442-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107735/
https://www.ncbi.nlm.nih.gov/pubmed/35570276
http://dx.doi.org/10.1186/s12879-022-07442-y

Ejemplares similares